Greenbrook provides Transcranial Magnetic Stimulation (TMS) therapy for individuals with treatment-resistant depression.
Greenbrook has raised $1.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2024.
Greenbrook's investors include Madryn Asset Management, Oxford Finance LLC, Alumni Capital Management, Greybrook Realty Partners, Masters Special Situations.
Greenbrook is headquartered in Mclean, United States.
Greenbrook provides Transcranial Magnetic Stimulation (TMS) therapy for individuals with treatment-resistant depression.
Greenbrook is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Greenbrook — Funding & Investors." VCBacked, February 22, 2024, https://www.vcbacked.co/company/greenbrook. Accessed August 13, 2026.
VCBacked. (2024). Greenbrook — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/greenbrook
{{cite web |title=Greenbrook — Funding & Investors |url=https://www.vcbacked.co/company/greenbrook |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated